Spencer Frederick A, Meyer Theo E, Gore Joel M, Goldberg Robert J
Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass 01655, USA.
Circulation. 2002 Jun 4;105(22):2605-10. doi: 10.1161/01.cir.0000017861.00991.2f.
Heart failure (HF) is an important predictor of poor outcome after acute myocardial infarction (AMI). However, limited data exist about the clinical significance of HF in the coronary reperfusion era and the impact of its timing on hospital outcomes. The objective of this study was to determine the clinical impact of HF complicating AMI in the National Registry of Myocardial Infarction (NRMI). A secondary objective was to determine differences in demographic and clinical characteristics, treatment, and hospital death rates in patients presenting with HF compared with those developing HF after presentation.
The study sample consisted of patients with AMI and without a history of HF included in the NRMI. Of 606 500 cases included from July 1, 1994 to June 30, 2000, 123 938 (20.4%) patients had HF at the time of hospital presentation and 52 220 (8.6%) developed HF thereafter. Patients with HF were older, more likely female, had more comorbidities, and were less likely to receive effective cardiac medications compared with patients without HF. The multivariable adjusted odds for in-hospital death were higher for patients with HF at presentation and thereafter (3.1 and 5.5, respectively) than those without HF.
Results from this nationwide registry suggest that the incidence and hospital death rates associated with HF complicating AMI remain high. Patients developing HF after hospital admission are at even greater risk than those presenting with HF. Effective cardiac therapies remain underutilized in these patients, and the reasons for this underutilization need to be explored.
心力衰竭(HF)是急性心肌梗死(AMI)后预后不良的重要预测因素。然而,在冠状动脉再灌注时代,关于HF的临床意义及其发生时间对住院结局的影响的数据有限。本研究的目的是确定在国家心肌梗死注册研究(NRMI)中,HF并发AMI的临床影响。次要目的是确定出现HF的患者与就诊后发生HF的患者在人口统计学和临床特征、治疗及住院死亡率方面的差异。
研究样本包括NRMI中纳入的急性心肌梗死且无HF病史的患者。在1994年7月1日至2000年6月30日纳入的606500例病例中,123938例(20.4%)患者在入院时即有HF,52220例(8.6%)此后发生HF。与无HF的患者相比,有HF的患者年龄更大,女性更多,合并症更多,且接受有效心脏药物治疗的可能性更小。入院时及此后有HF的患者院内死亡的多变量调整比值比更高(分别为3.1和5.5),高于无HF的患者。
这项全国性注册研究的结果表明,HF并发AMI的发病率和住院死亡率仍然很高。入院后发生HF的患者比入院时即有HF的患者风险更高。这些患者中有效心脏治疗的使用率仍然很低,需要探究这种低使用率的原因。